Reference6 articles.
1. D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):37-52. doi: 10.1016/j.hoc.2017.09.004. PMID: 29157618.
2. 2. Wong RSM. Unicentric Castleman Disease. Hematol Oncol Clin North Am. 2018 Feb;32(1):65-73. doi: 10.1016/j.hoc.2017.09.006. PMID: 29157620.
3. 3. van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. 2020 Dec 8;4(23):6039-6050. doi: 10.1182/bloodadvances.2020003334. PMID: 33284946; PMCID: PMC7724917.
4. 4. Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: Where are we now? Semin Diagn Pathol. 2016 Sep;33(5):294-306. doi: 10.1053/j.semdp.2016.05.006. Epub 2016 May 16. PMID: 27296355; PMCID: PMC5003700.
5. 5. Yamanuha J, Ballinger R, Coon D, Navin J. Carcinoid tumor presenting as a primary mesenteric mass: a case report and review of the literature. Hawaii Med J. 2009 Jul;68(6):137-9. PMID: 19653425.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献